TRCT
NAUT icon

Tower Research Capital (TRC)’s Nautilus Biotechnolgy NAUT Stock Holding History

Tower Research Capital (TRC)’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5
Closed -$10 – 5401
2025
Q4 		$10 Sell
5
-5,598
-100% -$9.18K ﹤0.01% 5108
2025
Q3 		$4.73K Sell
5,603
-15,978
-74% -$11.7K ﹤0.01% 4301
2025
Q2 		$15.6K Buy
21,581
+10,827
+101% +$8.13K ﹤0.01% 3805
2025
Q1 		$9.26K Sell
10,754
-2,477
-19% -$3.68K ﹤0.01% 3802
2024
Q4 		$22.2K Buy
13,231
+9,699
+275% +$23.2K ﹤0.01% 3105
2024
Q3 		$10.1K Sell
3,532
-6,806
-66% -$17.6K ﹤0.01% 3807
2024
Q2 		$24.2K Buy
10,338
+6,432
+165% +$16.8K ﹤0.01% 3652
2024
Q1 		$11.5K Sell
3,906
-691
-15% -$1.96K ﹤0.01% 3559
2023
Q4 		$13.7K Buy
4,597
+89
+2% +$255 ﹤0.01% 3938
2023
Q3 		$14.2K Buy
4,508
+2,291
+103% +$7.46K ﹤0.01% 3700
2023
Q2 		$8.58K Sell
2,217
-2,516
-53% -$7.25K ﹤0.01% 4409
2023
Q1 		$13K Sell
4,733
-1,079
-19% -$2.26K ﹤0.01% 3988
2022
Q4 		$10K Sell
5,812
-423
-7% -$817 ﹤0.01% 4037
2022
Q3 		$13K Sell
6,235
-13,251
-68% -$33.3K ﹤0.01% 4275
2022
Q2 		$52K Buy
19,486
+17,066
+705% +$63.5K ﹤0.01% 2842
2022
Q1 		$11K Sell
2,420
-150
-6% -$616 ﹤0.01% 4192
2021
Q4 		$14K Buy
2,570
+1,570
+157% +$8.4K ﹤0.01% 4089
2021
Q3 		$6K Buy
+1,000
New +$7.97K ﹤0.01% 4766
2021
Q2 		– Sell
-15
Closed – – 5711
2021
Q1 		$0 Buy
+15
New +$208 ﹤0.01% 5602

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ST
Sentinel Trust Houston, Texas $1.13B AUM 24.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Tower Research Capital (TRC)'s NAUT Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of Nautilus Biotechnolgy (NAUT) in Q1 2026, closing a stake of 5 shares — an estimated $10 sold.

Tower Research Capital (TRC) first reported a position in NAUT in Q1 2021 and held it in 19 quarters. The position peaked at $52K in Q2 2022. 81 funds tracked by Wall St. Rank hold NAUT as of Q1 2026.

  • Tower Research Capital (TRC) reported no remaining Nautilus Biotechnolgy position as of Q1 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 5 Nautilus Biotechnolgy shares in Q1 2026, an estimated $10.
  • Tower Research Capital (TRC) first reported a position in Nautilus Biotechnolgy in Q1 2021 and held it in 19 quarters.
  • Tower Research Capital (TRC)'s Nautilus Biotechnolgy position peaked at $52K in Q2 2022.
  • 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.